Logo

BIOVIA Biologics

Feb 19, 2015

Dassault Systemes BIOVIA (formerly Accelrys) has launched BIOVIA Biologics, a comprehensive data management and workflow solution that supports the discovery, optimization, and development of biotherapeutic candidates.

The release includes tools that help scientists manage, process, and understand high-volume candidate antibody sequence and cell line data; assess developabilty early, and customize workflows. It also supports sharing data and analysis results and reporting and offers cloud-based deployment options.  

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.